/ 128 Shares
22-Dec-2025 - 24-Dec-2025
₹ 108 - ₹ 114
₹ 14592.00
128
13,219,360
Face Value - ₹ 2/- Per Share
Listing at BSE, NSE
17,150 Application Required in Retail for 1 Time.
Registrar : Link Intime India Private Ltd
| Category | % | Shares/Amount |
|---|---|---|
| QIB | 75% | 7,726,880 Shares RS.88.00 CR |
| HNI 1 | 5% | 1,099,136 Shares RS.12.53 CR @ 613 FORM 1X |
| HNI 2 | 10% | 2,198,144 Shares RS.25.06 CR @ 1227 FORM 1X |
| Retail | 10% | 2,195,200 Shares RS.25.03 CR @ 17150 FORM 1X |
| Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
|---|---|---|
| 17150 FORM 1X | 613 FORM 1X | 1227 FORM 1X |
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Upto 2 Lakh) | 1 | 128 | ₹ 14,592 |
| Retail (Upto 2 Lakh) | 13 | 1664 | ₹ 189,696 |
| S-HNI (2 Lakh to 10 Lakh) | 14 | 1792 | ₹ 204,288 |
| S-HNI (2 Lakh to 10 Lakh) | 68 | 8704 | ₹ 992,256 |
| B-HNI (Above 10 Lakh) | 69 | 8832 | ₹ 1,006,848 |
24-Dec-2025 17:29
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 3,090,752 ₹ 35.23 Cr. | 8,188,928 ₹ 93.35 Cr. | 2.65x |
| HNI (<10 LAKH) | 1,099,136 ₹ 12.53 Cr. | 7,346,944 ₹ 83.76 Cr. | 6.68x |
| HNI2 (>10 LAKH) | 2,198,144 ₹ 25.06 Cr. | 11,552,896 ₹ 131.70 Cr. | 5.26x |
| RETAIL | 2,195,200 ₹ 25.03 Cr. | 41,879,808 ₹ 477.43 Cr. | 19.08x |
| Total | 8,583,232 | 68,968,576 | 8.04x |
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 3,090,752 ₹ 35.23 Cr. | 8,188,928 ₹ 93.35 Cr. | 2.65x |
| HNI (<10 LAKH) | 1,099,136 ₹ 12.53 Cr. | 7,346,944 ₹ 83.76 Cr. | 6.68x |
| HNI2 (>10 LAKH) | 2,198,144 ₹ 25.06 Cr. | 11,552,896 ₹ 131.70 Cr. | 5.26x |
| RETAIL | 2,195,200 ₹ 25.03 Cr. | 41,879,808 ₹ 477.43 Cr. | 19.08x |
| Total | 8,583,232 | 68,968,576 | 8.04x |
*Excluding Anchor
Total No. of Application Approx : ~256180 (14.94 Appwise)
| Appwise Subscription | ||
|---|---|---|
| Category | Total App | App wise |
| HNIBT | 3680.35 613 (For 1x) | 6.00x |
| HNIAT | 1275.22 1227 (For 1x) | 1.04x |
| RETAIL | 245125.00 17150 (For 1x) | 14.29x |
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.
Gujarat Kidney & Super Speciality Ltd.'s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Total Income | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| NET Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves and Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 | |
| Amount in ? Crore | ||||
The Company Gujarat Kidney IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Estimated Amount (? in Cr.) |
|---|---|---|
| 1 | Proposed acquisition of Parekhs Hospital at Ahmedabad. | 77.00 |
| 2 | Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. | 12.40 |
| 3 | Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | 30.10 |
| 4 | Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | 6.83 |
| 5 | Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | 1.20 |
| 6 | Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | |
| 7 | Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch | 10.78 |
Once you create your account, Login to Us.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.